{"slideshow_credits": null, "snippet": "The company may patent two genes linked to breast and ovarian cancer, but may not patent methods of \u201ccomparing\u201d or \u201canalyzing\u201d DNA sequences.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/08/17/business/court-reaffirms-right-of-myriad-genetics-to-patent-genes.html", "lead_paragraph": "The company may patent two genes linked to breast and ovarian cancer, but may not patent methods of \u201ccomparing\u201d or \u201canalyzing\u201d DNA sequences.", "headline": {"seo": "Court Reaffirms Right of Myriad Genetics to Patent Genes", "main": "Court Reaffirms Right of Myriad Genetics to Patent Genes", "print_headline": "Court Reaffirms Right of Myriad Genetics to Patent Genes"}, "_id": "53f9ef1538f0d84410bcb56e", "word_count": "465", "multimedia": [], "pub_date": "2012-08-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Myriad Genetics Inc", "name": "organizations", "is_major": "N", "rank": "1"}, {"value": "Genetics and Heredity", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Decisions and Verdicts", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Inventions and Patents", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Ovarian Cancer", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Breast Cancer", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Suits and Litigation", "name": "subject", "is_major": "N", "rank": "7"}, {"value": "Courts and the Judiciary", "name": "subject", "is_major": "N", "rank": "8"}, {"value": "Biotechnology", "name": "subject", "is_major": "N", "rank": "9"}, {"value": "University of Utah", "name": "organizations", "is_major": "N", "rank": "10"}], "blog": [], "subsection_name": null, "type_of_material": "News"}